Home Analyst Ratings Pivotal Research Group upgrades Under Armour Inc. to Buy and price...

Pivotal Research Group upgrades Under Armour Inc. [UAA] to Buy and price target to $20

Pivotal Research Group took its Under Armour Inc. [UAA] rating to the equivalent of a Buy from a ‎Hold, ‎and the price target to $20 from $15, in a research note dated January 04, 2021. That figure ‎represents ‎around a 16.48% premium from where the company’s shares closed on Thursday. ‎Meanwhile, Argus had ‎raised its rating on UAA to “Buy” from the earlier “Hold”, in a research note ‎produced for clients ‎November 18, 2020. In addition, there was an upgrade from Wells Fargo on ‎November 17, 2020. The ‎rater changed UAA from “an Equal weight” to “an Overweight”.

Get the ‎hottest stocks to trade every day before the market opens 100% ‎free. Click here ‎now. ‎‎

Is Under Armour Inc. [NYSE:UAA] a Good Buy ‎Right Now?

It should be noted that UAA ‎technical indicators for short, intermediate as well as ‎long term progress have placed an overall ‎average of 80% as Buy. The average signal changed from ‎‎100% Buy in the last week and compares with ‎‎100% Buy in the past month. Data from Under Armour ‎Inc.’s Trend Spotter indicated that the signals ‎were Rising. The stock current average is 4.6 million ‎shares in the past 20 days and the short term ‎average signal indicates a 50% Buy. In the last 50 days, ‎the average trading volume was 6.48 million ‎shares while the medium term average advocated for ‎‎100% Buy. The average long-term signal stands ‎at 100% Buy and the 100-day average volume stands at ‎‎6.65 million shares.‎‎


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


UAA Price Performance

On Wall Street, Under Armour Inc. [NYSE:UAA] ‎finished Thursday’s ‎session down -1.60% at $17.17. The stock went up to $17.48 at the same session ‎while its lowest single ‎day price was $17.10. In the last five days, it saw a fall of about -1.09%, Under ‎Armour Inc. shares ‎dropped by almost -20.51% since the beginning of the year. However, the share ‎price has dropped to ‎as low as -21.81% below its one year high. On 01/03/20, the company shares ‎recorded $21.96, the ‎highest single-day price it has got to in the last 52-weeks and a 52-week low was ‎seen on 05/14/20, the ‎same year at $7.15. The company’s shares have declined by -21.17% in the past ‎year. The 50-day SMA ‎achieved is $16.05 while the 200-day SMA is $11.66. Volume gained to 3.21 ‎million from 1.98 million in ‎the previous session.‎‎

UAA Stock Support And Resistance ‎Levels

On the 24-hour scale, the immediate backing is ‎perceived around 17.02 level, and in case ‎of violation of this particular level, it will cause more drop to ‎‎16.87 level. On the upper level, 17.63 is still ‎the key resistance. The stock may increase to the ‎subsequent resistance at 17.40. The Relative ‎Strength Index (RSI) pinned on the 14-day chart is 54.40, ‎implying a neutral technical stance while the ‎MACD stands at -0.12, meaning price will decrease in the ‎next trading period. Percent R indicator ‎moved to 59.91%, implying low price movement. Stochastic %K ‎at 39.17% suggest selling the stock.‎‎‎

What is the short interest in Under Armour Inc.?

Short interest in the Under Armour ‎Inc. ‎stock has surged, increasing by 1.54 million shares to total 14.03 million shares on Dec 14, 2020. ‎The ‎interest had seen shares on Nov 12, 2020 stand at 15.57 million, data from Yahoo Finance shows. ‎The ‎decrease of -10.98% suggests the stock saw some decreased bullish sentiment. The stock’s days ‎to ‎cover (short ratio) moved to while the shorted shares account for just 8.66% of the overall float for ‎the ‎stock.‎‎

Under Armour Inc.’s Biggest Shareholders: Who Owns Under Armour Inc. ‎‎[UAA]?

Filings by ‎The Vanguard Group, Inc. showed that the firm now holds a total of 19,101,853 ‎shares or roughly ‎‎10.13% of the outstanding UAA shares. This means their shares have increased by ‎‎859,338 from the ‎‎19,101,853 the investor reportedly held in its prior 13-F filing. With the conclusion of ‎the purchase, ‎Adage Capital Management LP updated stake is worth $259,835,595. Details in the latest ‎‎13F filings ‎reveal that Credit Suisse Securities acquired their 537.28% stake valued at $198,135,990. ‎During the last ‎quarter, Credit Suisse Securities raised 10,081,186 of its shares in Under Armour Inc. ‎while AKO Capital ‎LLP bought 10,112,291 shares. The BlackRock Fund Advisors’s holdings currently ‎number 9,983,568 ‎shares at $171417862.56. According to the firm’s last 13F report, SSgA Funds ‎Management, Inc. shares ‎in the company at filing stood at 8,176,761 shares, roughly $135,488,930.‎‎‎

UAA Earnings Forecast For The Current Quarter

Under Armour Inc. [UAA] is expected ‎to ‎report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give ‎the ‎company expected revenues of $1.26B and an earnings per share of -$0.07 for Dec 2020. ‎Looking ‎further ahead, the company is expected to report revenue of $1.1B at an EPS of -$0.05 for Mar ‎‎2021. ‎The estimates represent downside of 12.50% and 127.70% in the company’s revenue and ‎earnings per ‎share, respectively, on a year-on-year basis.‎‎

Get the ‎hottest stocks to trade every day before the market opens 100% ‎free. Click here ‎now. 

UAA Earnings Estimates For The Current ‎Year

For the ‎financial year, Under Armour Inc. [NYSE:UAA] is expected to bring in revenue of ‎‎$4.32B. The returns ‎are nearly $-950.0 million lower than the company’s actual revenue recorded in the ‎fiscal year 2019. In ‎terms of EPS for the 2020, estimate put it at -0.47, lower than that of FY19 by -$0.81. ‎Estimates put this ‎year’s earnings growth at -238.20%, 127.70% for the next, and at an annual -4.50% ‎over the next 5-year ‎period. As for sales, forecasts are for a decrease of -18.00% in the current fiscal ‎year and a further ‎‎12.50% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam